Di Fusco, M.; Sun, X.; Allen, K.E.; Yehoshua, A.; Berk, A.; Alvarez, M.B.; Porter, T.M.; Ren, J.; Puzniak, L.; Lopez, S.M.C.;
et al. Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine against Long COVID Symptoms: A US Nationwide Study. Vaccines 2024, 12, 183.
https://doi.org/10.3390/vaccines12020183
AMA Style
Di Fusco M, Sun X, Allen KE, Yehoshua A, Berk A, Alvarez MB, Porter TM, Ren J, Puzniak L, Lopez SMC,
et al. Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine against Long COVID Symptoms: A US Nationwide Study. Vaccines. 2024; 12(2):183.
https://doi.org/10.3390/vaccines12020183
Chicago/Turabian Style
Di Fusco, Manuela, Xiaowu Sun, Kristen E. Allen, Alon Yehoshua, Alexandra Berk, Mary B. Alvarez, Thomas M. Porter, Jinma Ren, Laura Puzniak, Santiago M. C. Lopez,
and et al. 2024. "Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine against Long COVID Symptoms: A US Nationwide Study" Vaccines 12, no. 2: 183.
https://doi.org/10.3390/vaccines12020183
APA Style
Di Fusco, M., Sun, X., Allen, K. E., Yehoshua, A., Berk, A., Alvarez, M. B., Porter, T. M., Ren, J., Puzniak, L., Lopez, S. M. C., & Cappelleri, J. C.
(2024). Effectiveness of BNT162b2 BA.4/5 Bivalent COVID-19 Vaccine against Long COVID Symptoms: A US Nationwide Study. Vaccines, 12(2), 183.
https://doi.org/10.3390/vaccines12020183